Apple Watch Hypertension Notification: A Promising Tool With Caveats

The Apple Watch’s hypertension notification feature, cleared by the US Food and Drug Administration (FDA) in September 2025, offers a modern avenue for identifying individuals with potentially undiagnosed high blood pressure. However, a recent study published in the Journal of the American Medical Association highlights that while the feature can successfully flag many cases, a significant number of individuals with hypertension may not receive an alert and false reassurance is possible.

How the Apple Watch Detects Hypertension

Unlike traditional blood pressure monitoring that requires a cuff, the Apple Watch utilizes photoplethysmography (PPG) signals to estimate blood pressure. This technology analyzes light reflected from the wrist to detect subtle changes in blood flow. When the algorithm detects patterns suggestive of hypertension, the user receives a notification, prompting them to confirm the reading with a traditional blood pressure measurement.

Study Findings: Positive and Negative Predictive Values

Researchers analyzed data from the National Health and Nutrition Examination Survey (2017-2020) to assess the feature’s performance. The study, led by investigators from the University of Utah and the University of Pennsylvania, found the positive predictive value (PPV) to be 69.1%, meaning that approximately 69.1% of individuals who receive a hypertension notification actually have high blood pressure. The negative predictive value (NPV) was 79.0%, indicating that 79.0% of those who do not receive a notification are truly normotensive.

Age-Related Variations in Alert Accuracy

The accuracy of the Apple Watch’s hypertension notification feature varies with age. For individuals under 30, an alert increased the probability of hypertension from 0.14 to 0.47. In contrast, for those 60 and older, an alert raised the probability from 0.45 to 0.81. Notably, a substantial proportion of individuals with undiagnosed hypertension, particularly in older age groups, may not receive any notification at all.

Implications for Population Screening

With over 200 million Apple Watch users worldwide, the Hypertension Notification Feature presents a significant opportunity for population-wide hypertension screening . However, the study emphasizes the potential for hypertension misclassification and the risk of false reassurance. Individuals receiving a negative notification should not forgo regular blood pressure screenings with a validated, cuff-based method.

Expert Perspective

“A large proportion of individuals unaware of their hypertension may be made aware,” the authors write. “However, an even larger proportion of individuals with undiagnosed hypertension could receive no alert at all. False reassurance may discourage some individuals with undiagnosed hypertension from obtaining appropriate screening or engaging with the health care system, resulting in missed opportunities for early detection and treatment.”

Key Takeaways

• The Apple Watch hypertension notification feature can identify some individuals with undiagnosed hypertension.
• The feature is not foolproof; a significant number of hypertensive individuals may not receive an alert.
• Accuracy varies with age, with older adults showing a higher probability of hypertension when alerted.
• The feature should not replace traditional blood pressure monitoring with a cuff.
• False reassurance is a potential risk, and regular screenings are crucial.

The Apple Watch’s hypertension notification feature represents a step forward in digital health and preventative care. However, it’s essential to understand its limitations and utilize it as a complement to, not a replacement for, established medical practices.